NASDAQ: AMGN       Amgen Inc
Last Price Today's Change   Day's Range   Trading Volume
214.10   +0.46 (0.22%)  212.30 - 215.025  596,913


Avg Volume (4 weeks):2,676,125
4 Weeks Range:212.30 - 227.19
4 Weeks Price Volatility (%):
52 Weeks Range:210.28 - 276.69
52 Weeks Price Volatility (%):
Average Price Target: 140.00
Price Target Upside/Downside: -74.10


No recent Headlines for this stock.

Business Background

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis-stimulating agents (ESAs), such as Aranesp (darbepoetin alfa) and EPOGEN (epoetin alfa); Sensipar/Mimpara (cinacalcet); XGEVA (denosumab); Prolia (denosumab); NEUPOGEN (filgrastim), and other marketed products, such as KYPROLIS (carfilzomib), Vectibix (panitumumab), Nplate (romiplostim), Repatha (evolocumab), BLINCYTO (blinatumomab), IMLYGIC (talimogene laherparepvec) and Corlanor (ivabradine). It focuses on human therapeutics for the treatment of serious illness in the areas of oncology/hematology, cardiovascular disease and neuroscience. Its product candidates in Phase III include Erenumab for episodic migraine, Aranesp for myelodysplastic syndromes, BLINCYTO for acute lymphoblastic leukemia and IMLYGIC for metastatic melanoma.

  Be the first to like this.


1. Daily Futures Trading Strategy 23 September 2021 Where Futures Lies
2. Stocks Rebound Amid Dovish Feds State of The Markets
3. Stocks On Dead Cat Bounce Ahead of FOMC State of The Markets
4. CryptoNews of the Week CryptoNews
5. Risk-Off Fueled Dollar Rally State of The Markets
I3 Messenger
Individual or Group chat with anyone on I3investor

2930  1412  216  6740 

Top 10 Active Counters
 EAR 6.63-15.04 
 AAL 21.15+0.63 
 AAPL 146.41+0.56 
 F 13.59+0.36 
 WRI 31.44-0.66 
 LCID 25.48+0.53 
 BB 10.775+1.215 
 CCL 24.98+1.37 
 VALE 14.915+0.054 
 BAC 41.675+1.535